Chemclin Diagnostics Co., Ltd. (SHA:688468)
China · Delayed Price · Currency is CNY 7.94
+0.08 (1.02%)
Feb 27, 2026, 3:00 PM CST
Chemclin Diagnostics Company Description
Chemclin Diagnostics Co., Ltd. engages in the research and development, production, and sale of clinical immune chemiluminescence diagnostic reagents and instruments.
Its products include LiCAA series of diagnostic reagents based on photo-induced chemiluminescence and CC series based on enzymatic chemiluminescence diagnostic reagents and instruments, primarily used for infectious diseases, such as hepatitis B, hepatitis C, AIDS, syphilis, hepatitis A, hepatitis E, etc.; and detection of tumor markers, thyroid hormones, reproductive endocrine hormones, cardiac markers, and inflammation.
The company was founded in 2007 and is headquartered in Beijing, China.
Chemclin Diagnostics Co., Ltd.
| Country | China |
| Founded | 2007 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 606 |
| CEO | Lin Li |
Contact Details
Address: Incubator Building, 1st and 6th Floors Beijing, 100094 China | |
| Phone | 86 06 5871 7511 |
| Website | chemclin.com |
Stock Details
| Ticker Symbol | 688468 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100005311 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Yanling Huang | Chief Financial Officer, Secretary and Director |
| Lin Li | Chairman and GM |
| Li Jin | Accounting Supervisor |
| Zheng Ming Huang | Deputy GM and Director |
| Yu Hui Liu | Core Technical Personnel |